Summary
Nick Simmonds is Professor of Practice (Respiratory Medicine) at the National Heart and Lung Institute (NHLI), Imperial College London and Associate Director of the Adult CF Centre at the Royal Brompton Hospital, London. His main research interests include difficult CF diagnosis and the investigation of novel CF therapies. He has been a Principal Investigator on numerous global multicentre trials and is on the Executive Committee of the European Cystic Fibrosis Society (ECFS) Clinical Trials Network. He has extensive experience of novel diagnostic techniques and is the Vice Coordinator of the ECFS Diagnostic Network. He is also on the Registry Research Committee of the UK CF Registry, a role which promotes the use of registries to better understand outcomes in CF.
Publications
Journals
Casey M, Simmonds NJ, 2024, Why don't anti-inflammatories work in cystic fibrosis?, Expert Rev Respir Med, Pages:1-3
De Wachter E, De Boeck K, Sermet-Gaudelus I, et al. , 2024, ECFS standards of care on CFTR-related disorders: Towards a comprehensive program for affected individuals., J Cyst Fibros
Sloan CM, Sherrard LJ, Einarsson GG, et al. , 2024, Inhaled antimicrobial prescribing for Pseudomonas aeruginosa infections in Europe., J Cyst Fibros
Hanger S, Felton I, Ukor E-F, et al. , 2024, The effectiveness of CFTR modulators in people with CF and rare mutations: A real-world study., Pediatr Pulmonol, Vol:59, Pages:221-224
Castellani C, Raraigh K, Nährlich L, et al. , 2023, Reply to the letter Regarding the article entitled "Standards for the care of people with CF: a timely and accurate diagnosis"., J Cyst Fibros